Biology and mechanisms
Neural signaling, sensitization, inflammation, cortical activity, and pathways associated with migraine.
Our research archive
Explore a historical record of supported projects spanning migraine biology, genetics, diagnosis, prevention, treatment, and care. Each summary is presented as research context—not as individual medical guidance or proof that an approach is effective.
Research themes
The archive reflects many kinds of inquiry, from laboratory models and genetic analysis to clinical studies and behavioral care. Findings should be interpreted in light of study design, population, limitations, and later evidence.
Neural signaling, sensitization, inflammation, cortical activity, and pathways associated with migraine.
Inherited variation, molecular profiles, and potential indicators that may support future research.
Drug, device, behavioral, and other interventions assessed in laboratory or clinical settings.
Diagnosis, prevention, acute treatment, disability, and family-centered care for younger people.
Research examining hormonal influences and biological differences associated with migraine.
Access, adherence, sleep, stress, quality of life, and the wider effects of migraine.
Historical projects
Project titles and outcomes are summarized from the supplied archive. “Underway” reflects the status recorded at the time and may not describe the project today. Cancelled projects are omitted from the detailed selection.
View the research team profile
The project investigated whether selectively changing endocannabinoid activity could offer a new direction for migraine treatment. Recorded as underway.
The study aimed to identify potential therapeutic targets by examining gene activity at the level of individual cells. Recorded as underway.
The project examined mitochondrial DNA and nuclear-encoded mitochondrial genes in families affected by migraine with aura.
Researchers studied neural dynamics that may contribute to migraine and medication-overuse headache.
A randomized study compared an inhaled cannabinoid intervention with placebo for acute migraine. The archived listing did not provide final results.
The V-MATCH project considered whether a virtual method could support assessment and treatment of chronic headache.
View the research team profile
The project explored genetic regions associated with migraine aura to identify relevant genes.
The study examined endogenous pain modulation and central sensitization in children with new daily persistent headache.
The project evaluated compounds affecting calcium channels in laboratory models and their potential therapeutic value.
Researchers investigated possible relationships between oral microbial patterns, inflammation, and headache in children.
The project explored how characteristics of light might be measured and studied in relation to migraine attacks.
View the research team profile
The study sought characteristics that might distinguish people who responded to treatment from those who did not.
This preclinical project investigated a non-paralytic modified molecule as a possible therapeutic approach.
The project examined known genetic variants in children and adolescents with migraine. The archived summary described common variants but did not establish a diagnostic test.
Researchers identified active substances in two preparations. One was tested in vitro, while technical limitations prevented testing of the other.
The project reported differences in selected microRNA profiles between study groups. Such findings require validation before clinical use.
The archived summary reported serotonin differences between migraine groups and controls, while leaving open questions about clinical application.
Laboratory work identified candidate inhibitors and examined a channel-modulation mechanism as a possible research target.
Next-generation sequencing identified known and new variants, while many cases remained without a definitive genetic explanation.
A small feasibility study supported further investigation of melatonin for adolescent migraine prevention; larger studies were needed to assess effectiveness.
The archived result did not find a meaningful difference in monthly headache days between metformin and placebo groups.
The study identified gaps between evidence-based guidance and treatments recorded for children, supporting greater clinician education.
View the research team profile
A sensory-sensitivity questionnaire showed potential for predicting response to one preventive medicine and warranted further study.
View the research team profile
Animal research linked BDNF signaling in the brainstem with sensitization, suggesting a pathway for continued investigation.
The work used light-sensitive cellular techniques to initiate and track cortical spreading depression in a laboratory model.
The project evaluated migraine over time and reported that a self-administered questionnaire performed comparably to a neurologist interview for identifying migraine in the study setting.
The archived trial summary found no treatment benefit for ibudilast and recorded more worsening among participants receiving the study drug.
View the research team profile
Laboratory findings suggested that stress-related nervous-system changes varied by sex and genetic susceptibility.
Animal research examined sex-related susceptibility and suggested that estrogen signaling may influence migraine mechanisms.
View the research team profile
The archived findings did not show broad benefit from visual-cortex stimulation for stopping acute attacks.
The project identified candidate variants associated with migraine in one family, providing leads for further investigation rather than general diagnostic conclusions.
The work examined how cortical spreading depression changes the activity of selected neurons and may relate to head pain.
A pilot study reported improved sleep efficiency and fewer attacks after a brief behavioral sleep intervention; pilot findings require confirmation.
Brain imaging examined internally produced opioid activity during pain, while questions about safe therapeutic modulation remained unresolved.
A mouse model was used to study trigeminal pain and the effect of blocking CGRP receptors, supporting continued therapeutic research.
The project reported glutamate-receptor gene variants associated with migraine in the studied population.
Behavioral and relaxation approaches were associated with improved symptoms and perceived anxiety control in children, with stronger results for the cognitive-behavioral group.
Animal research explored biological differences associated with migraine and suggested that treatment questions may differ by sex.
The project evaluated functional MRI as a method for observing brain-network changes in a rodent headache model.
The work established a large collection of genetic samples from people with and without migraine to enable later research.
A population-based analysis examined associations between migraine with aura in midlife and brain findings later in life.
Animal research examined persistent nervous-system changes after repeated opioid exposure and the possible role of CGRP.
The project demonstrated the feasibility of collecting usable saliva-based DNA samples by mail for large-scale genetics research.
Reading the archive: Early laboratory or pilot findings do not establish that an intervention is safe or effective. Some projects produced inconclusive or negative results, which can still help refine research questions and avoid unproductive directions.
How to read research
Scientific progress is cumulative. A promising mechanism must pass through several stages before it can inform routine care.
Researchers define a mechanism, population, intervention, or care problem to investigate.
Laboratory models, observational studies, and controlled trials answer different questions.
Sample size, design, comparison groups, and uncertainty affect what can be concluded.
Independent evidence and safety review are needed before findings can influence care.
Frequently asked questions
Practical guidance for interpreting historical project summaries and following related material.
No. Inclusion documents a research project. It does not endorse an intervention or establish safety, effectiveness, or suitability for any individual.
Preclinical models help researchers study mechanisms and identify questions for later work. Results from these models may not translate directly to people.
It is the status recorded in the historical source at that time. It should not be read as the project’s current status.
They can challenge assumptions, improve later study design, and indicate that a proposed approach needs revision or should not be pursued.
Consider its design, participant group, size, comparison treatment, outcome measures, duration, limitations, and whether independent studies support the findings.
Review the application information for available program and submission guidance.
No. The site provides general research context. A qualified clinician should advise on diagnosis, treatment, and individual risks.
Contact Migraine Research Fund for general website and research-resource enquiries.